Announcement

Collapse
No announcement yet.

New Drugs Stir Debate on Basic Rules of Clinical Trials

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • New Drugs Stir Debate on Basic Rules of Clinical Trials

    Speaking of controls and who wants to be one, here's an article on rethinking controls in new cancer meds trials.

    "Controlled trials have for decades been considered essential for proving a drug’s value before it can go to market. But the continuing trial of the melanoma drug, PLX4032, has ignited an anguished debate among oncologists about whether a controlled trial that measures a drug’s impact on extending life is still the best method for evaluating hundreds of genetically targeted cancer drugs being developed. "

    http://www.nytimes.com/2010/09/19/he...l.html?_r=1&hp
Working...
X